메뉴 건너뛰기




Volumn 9, Issue 11, 2001, Pages 3065-3075

Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZYL 4 (4 METHYLPIPERAZINYLCARBONYL)PHENOXY 1 [1 (PHENYLETHYL)AMINOCARBONYL]AZETIDIN 2 ONE; 3 BENZYLAZETIDIN 2 ONE DERIVATIVE; 4 (4 CARBOXYPHENOXY) 1 [(DIPHENYLMETHYL)AMINOCARBONYL] 3 (2 ETHOXYBENZYL)AZETIDIN 2 ONE; AZETIDINONE DERIVATIVE; CATHEPSIN G; CHYMASE; CHYMOTRYPSIN A; ENZYME INHIBITOR; TRYPSIN; UNCLASSIFIED DRUG; AZETIDINE DERIVATIVE; FUNCTIONAL GROUP; N [1 (1,3 BENZODIOXOL 5 YL)BUTYL] 3,3 DIETHYL 2 [4 [(4 METHYL 1 PIPERAZINYL)CARBONYL]PHENOXY] 4 OXO 1 AZETIDINECARBOXAMIDE;

EID: 0034801226     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(01)00209-7     Document Type: Article
Times cited : (62)

References (29)
  • 16
    • 0003416269 scopus 로고    scopus 로고
    • (b)Aoyama, Y.; Uenaka, M.; Konoike, T.; Hayakawa-Kajiwara, Y.; Naya, N.; Nakajima, M. Bioorg. Med. Chem. Lett. 2001, 11, 1691.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.